Speech-Language Pathologists in Woodside, NY Accepting Medicare

62 Speech-Language Pathologists found. Showing 1 - 20

Ms. Erin Lynn Reilly, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5128 30th Ave, Apt 3h, Woodside, NY 11377 Phone: 631-848-7992

Miss Reut Dahan, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Leanna Lynch Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Andrea Lenderman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Brittany Lynch, M.S. CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Charissa Chai Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 715-429-2000

Melissa Manlulu, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50-05 31st Avenue, Woodside, NY 11373 Phone: 516-770-1110

Nicole Hagan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42-00 72nd Street, Nyc Department Of Education- P.s. 12, Woodside, NY 11377 Phone: 516-395-9134

Jerry A Perez, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3962 64th St, Woodside, NY 11377 Phone: 347-262-3626

Naydeen Ortiz, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-540-2142

Amy Gabriel Alken Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 42-77 65th Place, Woodside, NY 11377 Phone: 718-429-2000

Abigail Nadia Canare Nicolas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5005 43rd Ave, Apt 3k, Woodside, NY 11377 Phone: 718-683-4032

Nicole Gusler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Aida Arias Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3044 69th St, Woodside, NY 11377 Phone: 718-205-0727

Dora Nisimov Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Mrs. Vickie Kakavas, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3352 62nd St, Woodside, NY 11377 Phone: 718-429-3141

Kendra A Bowman, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4277 65th Pl, Woodside, NY 11377 Phone: 718-429-2000

Cristina Arboleda, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3521 63rd St, Woodside, NY 11377 Phone: 646-421-3747

Erin Doreen Reynolds, MS, CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 7024 47th Ave, Woodside, NY 11377 Phone: 718-476-7163

Elizabeth Schmidt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6725 51st Rd, Woodside, NY 11377 Phone: 718-446-2120    Fax: 718-672-3117

News Archive

HHS report: Hospitals fall short in meeting error reporting requirements

The government report says the failure to report medical errors hampers providers' ability to identify and fix preventable problems. Meanwhile, new Medicare data shows hospitals are making little progress in reducing preventable readmissions.

Adnexus Therapeutics to become a subsidiary of Bristol-Myers Squibb

Bristol-Myers Squibb and Adnexus Therapeutics have announced the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Adnexus Therapeutics, developer of a new therapeutic class of biologics called Adnectins.

New genetic clues to dementia with Lewy bodies

Researchers have found that genetic alterations originally identified in people suffering from a rare disease may also be an important risk factor for the second most common form of dementia among the elderly.

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

Read more Medical News

› Verified 8 days ago

• 1(current)
• 2
• 3
• 4